Property and Bio-adhesiveness in Hydrogel Material with Content of Ketorolac and Gardeniae Fructus Hydrolysis Products

케토롤락과 치자엑스 가수분해물이 함유된 하이드로겔제의 물성 및 생체 부착성

  • Kim, Mi-Jeong (Department of Dental Hygiene, Vision University of Jeonju)
  • Received : 2010.03.18
  • Accepted : 2010.04.15
  • Published : 2010.04.30

Abstract

This study manufactured hydrogel, which was contained NSAIDs(non-steroidal anti-inflammatory drugs) Ketorolac tromethamine and hydrolyzed products of gardeniae fructus extract, and experimented viscosity, surface tension, tensile strength and bio-adhesiveness by using hairless mouse. Thus, it was performed in expectation for being probably able to develop as effective auxiliary agent of periodontal disease after non-surgical or surgical periodontal treatment. As a result, the following conclusions were obtained. 1. Out of KGE and KGH gel materials, the content of ketorolac tromethamine was 1.02~0.97%. The content of geniposide was 0.34% in KGE gel A and C. However, it got lower to 0.11% in KGH gel B and D. The content of genipin wasn't shown in KGE gel A and C, but was shown with 0.13% in KGH gel B and D. 2. As for viscosity according to temperature in gel material, the gel, which used independently Carbopol 940 as gel inoculant, maintained the higher viscosity than the gel, which added Poloxamer 407. The surface tension in each material showed 34.77~40.58 dyne/cm at 37. As for tensile strength in material, KGH gel B was shown the higher tensile strength in about 3.5 times compared to the control group. 3. As for bio-adhesiveness, the back-skin upper part(epidermis) and abdomen skin were shown to be 50.62 N in KGH gel B, thereby having indicated higher value in about 5 times compared to control group. The back-skin lower part(dermis) and abdomen skin were shown to be 35.93 N in KGH gel B, thereby having indicated higher value in about 3.5 times compared to control group.

소염진통제인 Ketorolac tromethamine에 치자엑스 복합제제를 혼합하여 4종의 하이드로겔을 제조한 다음 주성분의 확인, 점도, 표면장력, 인장강도 및 생체부착성 실험을 통해 다음과 같은 결론을 얻었다. 1. KGE 및 KGH gel 제제 중 Ketorolac tromethamine의 함량은 1.02~0.97%이었고, Geniposide의 함량은 KGE gel A와 C에서 0.34%이었으나, KGH gel B와 D에서 0.11%로 낮아졌고, Genipin의 함량은 KGE gel A와 C에서는 나타나지 않았으나, KGH gel B와 D에서 0.13%로 나타났다. 2. Gel 제제의 온도에 따른 점도는 gel 화제로 Carbopol 940을 단독으로 사용한 gel이 Poloxamer 407을 추가한 gel보다 더 높은 점도를 유지하였으며, 각 제제에서의 표면장력은 $37^{\circ}C$에서 34.77~40.58 dyne/cm를 나타냈다. 제제의 인장강도는 KGH gel B에서 대조군에 비하여 3.5배 정도 높은 인장강도를 나타냈다. 3. 생체부착성은 등피부 상부(표피층)와 배피부의 경우 KGH gel B 에서 50.62 N으로 나타나 대조군에 비해 5배 정도 높은 수치를 나타내었고, 등피부 하부(진피층)와 배피부의 경우 KGH gel B의 에서 35.93 N으로 나타나 대조군에 비해 3.5배 정도 높은 수치를 나타냈다.

Keywords

References

  1. Song KB et al.: The relationships betwteen periodontal indices and oral hygiene behaviour and knowledge about periodontal l1disease after periodontal treatment. J Korean Academy of Dental Health 26(1): 101-115. 2002.
  2. Back YR et al.: The effects of vitamin-C containing neutraceutical on periodontal wound healing as an adjunct to non-surgical or surgical periodontal treatment. J Korean Acad Periodontol 39(2): 151-166. 2009.
  3. Larsen T: In vitro release of Doxycycline from Bioabsorbable materials and acrylic strips. J Periodontol 61(1): 30-34. 1990. https://doi.org/10.1902/jop.1990.61.1.30
  4. Minabe Metal.: Application of a local drug delivery system to periodontal therapy: I . Development of collagen preparations with immobilized tetracycline. J Periodontol 60(2): 113-111, 1988.
  5. Williams RC el aL: Altering the progression of human alveolar bone loss with the non steroidal anti-inflammatory durg flurbiprofen. J PeriodontoI 60(9): 485-490. 1989. https://doi.org/10.1902/jop.1989.60.9.485
  6. Buckley MMT. Brogden RN: Ketorolac. A review of its pharmacodynamic and Pharmacokinetic properties and therapeutic potenital. Drug 39(1): 86-109, 1990. https://doi.org/10.2165/00003495-199039010-00008
  7. Grandos-Soto V et al.: Evidence against the participation of $\mu$ and -opioid receptors in the analgesic activity of ketorolac, in rats. J Pharm Pharmacol 47(6): 514-517. 1995. https://doi.org/10.1111/j.2042-7158.1995.tb05841.x
  8. Jeffcoat MK et al.: A comparison of topical ketorolac. systemic flurbiprofen. and placebo for the inhibition of bone loss in adult periodontitis. J Periodontol 66(5): 529-337. 1995. https://doi.org/10.1902/jop.1995.66.5.329
  9. Chun MK. Kwak BT. Choi UK: Preparation of buccal patch composed of carbobol. poloxamer and hydroxypropyl methylcellulose. Arch Pharm Res 26(11): 913-978, 2003.
  10. Nam HG Lee CH. Shin YH: Effect of skin penetration enhancer on the drug release from indomethacin-son hydrogel. J Kor Pharm Sci 32(1): 35-40. 2002.
  11. Akao T. Kobashi K, Aburada M: Enzymatic studies on the animal and intestinal bacterial methabolism of geniposide. Biol Pharm Bull 17(12): 1513-1516. 1994. https://doi.org/10.1248/bpb.17.1513
  12. Kawata Y et al.: Formation of nitrogen containing metabolites from geniposide and gardenoside by human intestinal bacteria. Planta Med 51(6): 536-542. 1991.
  13. Sung HW et al.: In vitro surface characterization of a biological patch fixed with naturally occurring crosslinking agent. Biomaterials 21(13): 1353-1362. 2000. https://doi.org/10.1016/S0142-9612(00)00017-X
  14. Kim MJ : Skin permeation and periodontits alleviation effect of hydrogel containing ketorolac tromethamine and hydrolysis products of gardeniae fructus. J of Dental Hygiene Science 5(3): 113-117. 2005.